Preventive effect of taurine on experimental type II diabetic nephropathy

Author(s): Lin S, Yang J, Wu G, Liu M, Luan X, et al.

Abstract

Background: It has been verified that taurine has some preventive effects on diabetes and its complications when used alone or together with other drugs, but there are few reports about taurine on the prevention of diabetic nephropathy, the mechanisms of which are still unknown.

Methods: Taurine was administered to type diabetic rats induced by high fat high sugar diet combined with STZ injection. The preventive effect of taurine on diabetic nephropathy was investigated by detecting blood glucose, lipid metabolism, kidney function and glomerular basement membrane metabolism.

Results: Taurine could lower blood glucose, TG, TC, BUN, Scr, NAG, U-PRO, the expression of laminin B1(LBN1) mRNA, and increase HDL-C of diabetic rats.

Conclusions: The results indicated that taurine could prevent the occurrence and development of diabetic nephropathy by decreasing blood glucose, improving lipid metabolism, glomerular basement membrane metabolism, and kidney function.

Similar Articles

The early natural history of nephropathy in Type 1 Diabetes: III

Author(s): Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, et al.

The pathogenesis of diabetic nephropathy

Author(s): Dronavalli S, Duka I, Bakris GL

Patterns of renal injury in NIDDM patients with microalbuminuria

Author(s): Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, et al.

New and old markers of progression of diabetic nephropathy

Author(s): Jerums G, Premaratne E, Panagiotopoulos S, Clarke S, Power DA, et al.

Recent and potential developments of biofluid analyses in metabolomics

Author(s): Zhang A, Sun H, Wang P, Han Y, Wang X

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Author(s): Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al.

A metabonomic comparison of urinary changes in Zucker and GK rats

Author(s): Zhao LC, Zhang XD, Liao SX, Gao HC, Wang HY, et al.

Scaling and normalization effects in NMR spectroscopic metabonomic data sets

Author(s): Craig A, Cloarec O, Holmes E, Nicholson JK, Lindon JC

Normalization of urinary drug concentrations with specific gravity and creatinine

Author(s): Cone EJ, Caplan YH, Moser F, Robert T, Shelby MK, et al.

Normalization strategies for metabonomic analysis of urine samples

Author(s): Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, et al.

Comprehensive profiling and quantitation of amine group containing metabolites

Author(s): Boughton BA, Callahan DL, Silva C, Bowne J, Nahid A, et al.

Proposed minimum reporting standards for data analysis in metabolomics

Author(s): Goodacre R, Broadhurst D, Smilde A, Kristal B, Baker J, et al.

A gentle guide to the analysis of metabolomic data

Author(s): Steuer R, Morgenthal K, Weckwerth W, Selbig J

Centering, scaling, and transformations: improving the biological information content of metabolomics data

Author(s): van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ

Multiple hypothesis testing

Author(s): Shaffer JP

Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations

Author(s): Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, et al.

Metabolite profiles and the risk of developing diabetes

Author(s): Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al.

Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

Author(s): Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, et al.

Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study

Author(s): Merheb M, Daher RT, Nasrallah M, Sabra R, Ziyadeh FN, et al.